Organon’s Asenapine Shows Less Weight Gain Than Zyprexa In Phase III Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Patients taking asenapine had approximately two-fold lower incidence of clinically significant weight gain; efficacy profile was similar to Lilly’s olanzapine.